Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens-Reference-Cited by-同舟云学术

Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens

Published:2002-10 Issue:1 Volume:119 Page:144-154
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Parker Jane E.,Shafi Tariq,Pagliuca Antonio,Mijovic Aleksandar,Devereux Stephen,Potter Mike,Prentice H. Grant,Garg Mamta,Yin John A.,Byrne Jenny,Russell Nigel H.,Mufti Ghulam J.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03796.x/fullpdf

Reference22 articles.

1. Tetranucleotide repeat polymorphism in the vWF gene;Van Amstel;Nucleic Acids Research,1990

2. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome;Anderson;Blood,1993

3. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia;Anderson;British Journal of Haematology,1996

4. Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score;Appelbaum;Leukemia,1998

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2022-01

2. Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI);Bone Marrow Transplantation;2019-09-26

3. Low Body Mass Index and Myeloablative Conditioning Regimen Prolong the Duration of Parenteral Nutrition During Hematopoietic Stem Cell Transplantation;Annals of Nutrition and Metabolism;2019

4. Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia;Current Treatment Options in Oncology;2018-10-27

5. Nutrition Support of the Hematopoietic Cell Transplant Recipient;Thomas’ Hematopoietic Cell Transplantation;2016-01-01